gold has been researched along with etoposide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asphahani, F; Buckmaster, R; Thein, M; Xu, J; Zhang, M | 1 |
Adam, V; Eckschlager, T; Jimenez, AM; Kizek, R; Kopel, P; Kremplova, M; Kudr, J; Masarik, M; Nejdl, L; Ruttkay-Nedecky, B; Skalickova, S; Stiborova, M | 1 |
Chen, W; Clement, S; Deng, W; Engel, A; Goldys, EM; Guller, A; Zhao, Z | 1 |
Atar, N; Özkan, A; Yola, ML | 1 |
4 other study(ies) available for gold and etoposide
Article | Year |
---|---|
Detection of drug-induced cellular changes using confocal Raman spectroscopy on patterned single-cell biosensors.
Topics: Antineoplastic Agents; Apoptosis; Biosensing Techniques; Cell Adhesion; Cell Line, Tumor; Cell Survival; Etoposide; Flow Cytometry; Gold; Humans; In Situ Nick-End Labeling; Medulloblastoma; Microarray Analysis; Spectrum Analysis, Raman; Time Factors | 2009 |
Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide).
Topics: DNA, Antisense; Doxorubicin; Drug Delivery Systems; Ellipticines; Etoposide; Fluorescence; Gold; Humans; Liposomes; Magnetite Nanoparticles; N-Myc Proto-Oncogene Protein; Neoplasms | 2016 |
Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Etoposide; Fluoresceins; Folic Acid; Gene Silencing; Gold; HCT116 Cells; Humans; Liposomes; Metal Nanoparticles; Mice; Oligoribonucleotides, Antisense; PC12 Cells; Photochemotherapy; Photosensitizing Agents; Rats; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Singlet Oxygen; Verteporfin; X-Rays; Xenograft Model Antitumor Assays | 2018 |
Enhanced surface plasmon resonance (SPR) signals based on immobilization of core-shell nanoparticles incorporated boron nitride nanosheets: Development of molecularly imprinted SPR nanosensor for anticancer drug, etoposide.
Topics: Antineoplastic Agents; Biosensing Techniques; Boron Compounds; Dielectric Spectroscopy; Etoposide; Gold; Humans; Metal Nanoparticles; Molecular Imprinting; Neoplasms; Polymers; Spectroscopy, Fourier Transform Infrared; Surface Plasmon Resonance | 2019 |